Beijing Biosis Healing Biological Technology
PrivateLast Round
Series D
Jul 4, 2023
Total Funding Raised
$11.51M
Company Overview
Beijing Biosis Healing Biological Technology operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series D round in July 2023.
Beijing Biosis Healing Biological Technology is a medical supplies company that provides regenerative surgical bio-materials, implantable soft tissue repair mesh, and intelligent minimally invasive surgical instruments.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Biosis Healing Biological Technology Comparables
Compare Beijing Biosis Healing Biological Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cook Group Incorporated | 81% | |
| Guanhao Biotech Co Ltd | 77% | |
| Medprin Regenerative Medical Technologies Co. Ltd. | 77% |
For institutional investors. Book with your work email.
Beijing Biosis Healing Biological Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 4, 2023 | ||||
| Series D | Sep 19, 2022 | ||||
| Strategic | Dec 30, 2020 | ||||
| Strategic | Feb 3, 2020 | ||||
| Series C Extension | Jun 14, 2019 | ||||
Series C | Jan 9, 2019 |
For institutional investors. Book with your work email.
Beijing Biosis Healing Biological Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qianshan Capital Management Co., Ltd. | Series B Extension |
| NewMargin Ventures | Strategic |
| Dingxin Capital | Series B, Series A |
| Ying Capital | Series D |
| Guangdong Technology Financial Group | Series C Extension |
| Morgan Stanley China | Series D |
| Galaxy Yuanhui Investment Co., Ltd. | Series C Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 4, 2023
Raised Series D round with participation from Morgan Stanley China.
- Sep 19, 2022
Raised Series D round with Ying Capital participating.
For institutional investors. Book with your work email.
Beijing Biosis Healing Biological Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beijing Biosis Healing Biological Technology's valuation, stock price, and market status.
Is Beijing Biosis Healing Biological Technology a public or private company?
Beijing Biosis Healing Biological Technology is a private company.
What is the current stock price of Beijing Biosis Healing Biological Technology?
Beijing Biosis Healing Biological Technology is a private company, so its shares have no public market price. Caplight tracks Beijing Biosis Healing Biological Technology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beijing Biosis Healing Biological Technology worth (valuation)?
Valuation information for Beijing Biosis Healing Biological Technology is not publicly available.
Can I buy Beijing Biosis Healing Biological Technology stock?
Beijing Biosis Healing Biological Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beijing Biosis Healing Biological Technology's last funding round?
Beijing Biosis Healing Biological Technology's most recent funding round was Series D on July 4, 2023.
Who are the main investors in Beijing Biosis Healing Biological Technology?
Key investors in Beijing Biosis Healing Biological Technology include Proxima Ventures Ltd..
Will Beijing Biosis Healing Biological Technology IPO soon?
No public IPO plans have been announced for Beijing Biosis Healing Biological Technology.
How can I track Beijing Biosis Healing Biological Technology secondary market activity?
Caplight tracks bids, offers, and trades in Beijing Biosis Healing Biological Technology's shares on secondary markets.